Results 221 to 230 of about 265,886 (307)

Favorable short-term survival in locally advanced cervical cancer with optimal pathological response after neoadjuvant chemoimmunotherapy: a real-world analysis. [PDF]

Front Immunol
Zhao L, Zhai Q, Zhang W, Wen L, Fu X, Xie X, Jin X, Zhang N, Meng Y, Li L, Gu C.   +10 more
europepmc   +1 more source

Circ_0006174 Drives Triple Negative Breast Cancer Progression and Immune Escape Through Regulating miR‐3139/PD‐L1 Axis

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Triple‐negative breast cancer (TNBC) is characterized as an aggressive malignancy with limited therapeutic options. The circular RNA circ_0006174 has been implicated in oncogenic processes across various cancers; however, its specific role in the pathogenesis of TNBC remains unclear.
Yong‐Zhe Tang, Li Yang, Ling Wang, Xiao‐Qing Zhang, Jie Wang   +4 more
wiley   +1 more source

Robotic‐Assisted Versus Laparoscopic‐Assisted Colectomy: Findings on Short‐Term Outcomes From A Multi‐Institutional Propensity Score‐Matched Study

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT The present study compared the short‐term outcomes and perioperative complications of robotic‐assisted colectomy (RAC) and laparoscopic‐assisted colectomy (LAC) in patients with colon cancer. This retrospective study included patients with histologically confirmed colon adenocarcinoma who underwent either RAC or LAC at five medical centers in ...
Ching‐Wen Huang, Chien‐Chih Chen, Jeng‐Fu You, Yi‐Ho Cheng, Feng‐Fan Chiang, Jaw‐Yuan Wang   +5 more
wiley   +1 more source

UCCL-IKF-AIO-STO-0124 NeoART-an international phase Ib/II platform trial investigating trastuzumab deruxtecan (T-DXd) combined with neoadjuvant chemotherapy for HER2-positive, resectable esophagogastric adenocarcinoma (EGA). [PDF]

ESMO Gastrointest Oncol
Stocker G, Hacker UT, Obermannová RL, Ilhan-Mutlu A, Junge S, Pauligk C, Al-Batran SE, Goetze TO, Lordick F.   +8 more
europepmc   +1 more source

Risk Factors Influencing Efficacy and Prognosis Evaluation of Neoadjuvant Systemic Therapy in Triple‐Positive Breast Cancer

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT To identify the determinants of the response to neoadjuvant systemic therapy (NST) in triple‐positive breast cancer (TPBC), we retrospectively enrolled 520 patients with human epidermal growth factor receptor 2 (HER2)‐positive breast cancer who were treated at The First Affiliated Hospital of Chongqing Medical University between January 2015 ...
Lin‐Rui Miao, Hao Liu, Hai‐Ying Yu, Jian Chen, Ming‐Yu Yang, Ya‐Lan Zhang, Gang Tu, Ling‐Feng Tang   +7 more
wiley   +1 more source

Case Report: Ultrasound features of pathological complete response in middle and low rectal cancer with high microsatellite instability after neoadjuvant immunotherapy: a case series. [PDF]

Front Immunol
Liang L, Wang Q, Chen Y, Zhang X, Zhou Z, Nie F.   +5 more
europepmc   +1 more source

Data‐Independent Acquisition Mass Spectrometry in Tumor Classification and Cancer Biomarker Research

Mass Spectrometry Reviews, EarlyView.
Abstract Cancer treatment is far from optimal also because current classification systems do not reflect the complex molecular status of the tumor and its phenotype in sufficient detail. To construct molecular tumor classifiers, omics tools provide complex molecular data reflecting many aspects from genotype to phenotype.
Jan Simonik, Petr Lapcik, Pavla Bouchalova, Pavel Bouchal   +3 more
wiley   +1 more source

Analysis of Factors Related to Lymph Node Metastasis Following Neoadjuvant Chemotherapy for Breast Cancer: Correlation Between Plasma Exosomal Circular RNA and Metastasis. [PDF]

Breast Cancer (Dove Med Press)
Ma S, Huang Y, Yang Q, Liu X, Zhang Z, Yan B.   +5 more
europepmc   +1 more source

Mathematical Analysis and Simulations of a Cancer Model With Interleukins and Delayed Immunotherapy

Mathematical Methods in the Applied Sciences, EarlyView.
ABSTRACT A new system of delayed differential equations for tumor‐immune system interactions is proposed and studied. The system describes the interactions between tumor cells and the immune system at the most aggressive phase of cancer, where tumor cells have developed mechanisms from earlier stages to evade immune responses.
Laid Boudjellal, Ana Jacinta Soares, Maria Joana Torres   +2 more
wiley   +1 more source

Neoadjuvant transarterial chemoembolization with tyrosine kinase and immune checkpoint inhibitors improves survival from resectable hepatocellular carcinoma in a multicenter, retrospective study (GUIDANCE002). [PDF]

Commun Med (Lond)
Yang DL, Qin C, Peng N, Liu SP, Yu YQ, Nong JL, Zeng FJ, Su Z, Yang YY, Yang FQ, Li MJ, Wu MS, Wang XY, Liang YR, Li FX, Chen SC, Lai YC, Pang QQ, Zhong TM, Yan YH, Zhang YY, Ye L, Dong XF, Li WF, Liu J, Yao HB, Wu PS, Mao XS, Ou JJ, Chen YZ, Wang GD, Chen K, Deng ZJ, Su JY, Qiu GG, Liu ZD, Wang JM, Zhang Y, Liang XM, Xiang BD, Ma L, Zhong JH, GUIDANCE investigators.   +42 more
europepmc   +1 more source